In the pharmaceutical sector, continuous manufacturing (CM) has emerged as a transformative technology with the potential to revolutionize the industry. As drugmakers seek to enhance efficiency, ...

GenX™ validation opens a pathway to a step change in titanium production economics. Moving beyond the batch model used in conventional Kroll titanium production, continuous processing offers the ...

The US Food and Drug Administration (FDA) has issued draft guidance to assist manufacturers in complying with its good manufacturing practice (GMP) regulations under 21 CFR 211.110 governing batch ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

Fed-batch and batch bioprocessing still dominate monoclonal antibody (mAb) production, but that must change if mAbs are to become economically viable therapeutic options. Current production techniques ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

Fragmented plant data across silos drives late investigations and corrective action; connected architectures unify PAT, sensors, batch, quality, and maintenance signals to enable earlier risk ...

As more manufacturers explore demand-driven manufacturing as a production model, one common concern is whether demand-driven manufacturing and batch scheduling can live in harmony. Good news: They can ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Within the process industry, the chemical and pharmaceutical ...

As noted in the first installment of this series investigating spending trends on automation technology across the discrete, batch, and continuous process industry verticals, this second installment ...

As regulatory enforcement surges, life science manufacturers must shift away from paper-based systems to ensure compliance.